Skip to main content

Table 2 Results

From: Bilateral hip arthroplasty: is 1-week staging the optimum strategy?

 

Cumulative hospital length of stay (days)

Cumulative time until pain-free (weeks)

Time to independent living (weeks)

Return to leisure activities (weeks)

Return to sport (weeks)

Return to work-Part time (weeks)

Return to Work - Full time (weeks)

All Hip Arthroplasty

       

Group 1

11.9

20.9

11.7

13.4

24.5

14.0

21.0

Group 2

9.1; (4.5, 4.6)

28.9; (15.8,13.1)

17.4; (9.3, 8.1)

22.2; (12.6, 9.6)

32.0; (17.1, 14.9)

17.2; (8.8, 8.4)

29.7; (15.4, 14.3)

p-value

p < 0.01; (p = 0.81)

p = 0.03; (p < 0.01)

p = 0.02; (p = 0.25)

p < 0.01; (p < 0.05)

p = 0.21; (p = 0.50)

p = 0.04; (p = 0.72)

p < 0.05; (p = 0.65)

Hip Resurfacing

       

Group 1

11.1

16.9

11.1

15.7

24.2

14.1

20.2

Group 2

7.3; (3.6, 3.7)

26.0;(14.5, 11.5)

15.6; (8.1, 7.5)

22.4; (12.1, 10.3)

34.0; (18.3, 15.7)

15.1; (7.5, 7.5)

22.9; (12.2, 10.7)

p-value

P < 0.01; (p = 0.59)

p = 0.04; (p = 0.04)

p = 0.19; (p = 0.47)

p = 0.16; (p = 0.43)

p = 0.33; (p = 0.67)

p = 0.60; (p = 1.0)

p = 0.66; (p = 0.65)

Total Hip Replacement

       

Group 1

12.6

24.1

12.1

11.5

24.8

13.8

22.0

Group 2

10.4; (5.2, 5.2)

31.0;(16.7, 14.3)

18.7; (10.2, 8.5)

22.0; (12.9, 9.1)

30.8; (16.3, 14.4)

19.3; (10.0, 9.3)

35.8; (18.2, 17.6)

p-value

p < 0.01; (p = 1.0)

p = 0.22; (p = 0.03)

p = 0.06; (p = 0.34)

p < 0.01; (p = 0.06)

p = 0.44; (p = 0.62)

p = 0.03; (p = 0.67)

p = 0.02; (p = 0.81)

Comparing HR and THR in Group 1

11.9, 12.6 p < 0.01

16.9, 24.1 p = 0.34

11.1, 12.1 p = 0.82

15.7, 11.5 p = 0.25

24.2, 24.8 p = 0.92

18.6, 13.8 p = 0.30

20.2, 22.0 p = 0.76

Comparing HR and THR in Group 2

7.3, 10.4 p < 0.01

26.0, 31.0 p = 0.02

15.6, 18.7 p = 0.23

22.4, 22.0 p = 0.93

34.0, 30.8 p = 0.73

15.1, 19.3 p < 0.05

22.9, 35.8 p = 0.03

  1. Key: HR - Hip Resurfacing, THR - Total Hip Replacement
  2. P-values: The first figure compares Groups 1 and 2, the second figure (in parentheses) compares differences between consecutive operations in Group 2 patients.